Not Yet Recruiting PHASE4 INTERVENTIONAL 3-arm NCT07238452

Optimising Pacing Therapy, Integrated Medical Therapy, and Catheter AbLation for Atrial Fibrillation in Heart Failure Trial (OPTIMAL AF-HF)

Sponsor: University of British Columbia

Conditions Atrial Fibrillation (AF) Heart Failure With Reduced Ejection Fraction

Interventions Atrioventricular Node Ablation Pharmacological Rate Control Pulmonary Vein Isolation

Updated 1 time since 2025 Last updated: Nov 21, 2025 Started: Dec 1, 2025 Primary completion: Dec 1, 2032 Completion: Jan 1, 2033

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Atrial Fibrillation (AF) and Heart Failure With Reduced Ejection Fraction, this trial is actively recruiting participants. The trial is conducted by University of British Columbia and has accumulated 1 data snapshot since 2025. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — PHASE4 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of British Columbia

Data source: University of British Columbia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.